Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Raymond G. Morris
Clinical Inhibition of CYP2D6-catalysed Metabolism by the Antianginal Agent Perhexiline
British Journal of Clinical Pharmacology
Pharmacology
Related publications
Inhibition of the Copper-Catalysed Thermal Oxidative Degradation of Polypropylene by Oxanilide
The Journal of the Society of Chemical Industry, Japan
The Relationship Between Clinical Pharmacokinetics of Aripiprazole and CYP2D6 Genetic Polymorphism: Effects of CYP Enzyme Inhibition by Coadministration of Paroxetine or Fluvoxamine
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Mechanism of Inhibition of Horseradish Peroxidase-Catalysed Iodide Oxidation by EDTA
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Inhibition ofPropionibacterium Acneslipase Activity by the Antifungal Agent Ketoconazole
Microbiology and Immunology
Virology
Immunology
Microbiology
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen
Frontiers in Pharmacology
Pharmacology
Significantly Lower CYP2D6 Metabolism Measured as the O/N -Desmethylvenlafaxine Metabolic Ratio in Carriers of CYP2D6*41 Versus CYP2D6*9 or CYP2D6*10 - A Study on Therapeutic Drug Monitoring Data From 1,003 Genotyped Scandinavian Patients
British Journal of Clinical Pharmacology
Pharmacology
Inhibition of Alveolar Macrophage 5-Lipoxygenase Metabolism by Auranofin
Biochemical Pharmacology
Biochemistry
Pharmacology
Comparison of Hemodynamic Effects Between .BETA.-blocking Agents and a New Antianginal Agent, Diltiazem Hydrochloride.
Japanese Circulation Journal
Efficacy Decision for Antianginal Agents by Treadmill Load Test.
Japanese Journal of Electrocardiology
